Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 0.2508
-0.0092 (-3.54%)
Sep 10, 2025, 2:58 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 662.92 million as of September 10, 2025. Its market cap has increased by 157.99% in one year.
Market Cap
662.92M
Enterprise Value
677.05M
Revenue
265.77M
Ranking
n/a
PE Ratio
8.34
Stock Price
0.25
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 662.92M, an increase of 405.83%. That is a compound annual growth rate of 18.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 685.35M | 178.67% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | 1.66B | 211.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.90B |
| Sectra AB | 62.81B |
| Getinge AB | 57.14B |
| Camurus AB | 43.26B |
| Medicover AB | 40.46B |
| Asker Healthcare Group AB | 36.45B |
| BioArctic AB | 25.10B |
| AddLife AB | 21.67B |